pharmaceutical combinations comprising an anti-bst-1 antibody and a cytidine analog

摘要

the invention relates to pharmaceutical combinations comprising antibodies against bst1 (adp-ribosyl cyclase 2) together with a cytidine analogue or a pharmaceutically acceptable salt thereof, and methods for treating diseases, for example, cancers mediated by expression / activity bst1 (adp-ribosyl cyclase 2) and / or associated with abnormal expression / activity of bst1.